Balance Sheet
Cash Flow Statement
AcquisitionsBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENvue Medical (FEED) Share-based Compensation (2017 - 2024)

Historic Share-based Compensation for ENvue Medical (FEED) over the last 10 years, with Q4 2024 value amounting to $355.8 million.

  • ENvue Medical's Share-based Compensation rose 2151.55% to $355.8 million in Q4 2024 from the same period last year, while for Mar 2025 it was $355.9 million, marking a year-over-year increase of 2144.86%. This contributed to the annual value of $356.0 million for FY2024, which is 2150.17% up from last year.
  • ENvue Medical's Share-based Compensation amounted to $355.8 million in Q4 2024, which was up 2151.55% from $58000.0 recorded in Q3 2024.
  • Over the past 5 years, ENvue Medical's Share-based Compensation peaked at $355.8 million during Q4 2024, and registered a low of -$190000.0 during Q4 2020.
  • In the last 5 years, ENvue Medical's Share-based Compensation had a median value of $99000.0 in 2021 and averaged $52.8 million.
  • Per our database at Business Quant, ENvue Medical's Share-based Compensation plummeted by 19547.74% in 2020 and then soared by 46531184.21% in 2022.
  • Over the past 5 years, ENvue Medical's Share-based Compensation (Quarter) stood at -$190000.0 in 2020, then surged by 140.0% to $76000.0 in 2021, then soared by 465311.84% to $353.7 million in 2022, then dropped by 17.21% to $292.8 million in 2023, then increased by 21.52% to $355.8 million in 2024.
  • Its last three reported values are $355.8 million in Q4 2024, $58000.0 for Q3 2024, and $107000.0 during Q1 2024.